Texas 2013 - 83rd Regular

Texas House Bill HB2529

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to disease control pilot programs to reduce the risk of certain communicable diseases.

Impact

If enacted, HB 2529 will significantly modify the Health and Safety Code by adding provisions for the operation of disease control pilot programs. These programs will be operated by local health authorities or designated organizations, focusing on anonymous needle exchange systems as part of addiction recovery efforts. Additionally, participating counties will be responsible for funding these initiatives, which may include offering education on disease transmission, prevention measures, and referrals to health-related services. It is expected that such programs could decrease rates of intravenous drug use and minimize risks associated with improperly disposed needles.

Summary

House Bill 2529 aims to establish disease control pilot programs within specific Texas counties to mitigate the risk of certain communicable diseases such as HIV, hepatitis B, and hepatitis C. The bill emphasizes the importance of education and treatment for individuals struggling with drug addiction, particularly through partnerships with community-based and faith-based organizations. By creating a network of support, the bill seeks to reduce the transmission of blood borne diseases and enhance public health outcomes through targeted intervention efforts.

Sentiment

The sentiment surrounding HB 2529 appears to be supportive among health advocates and community leaders who see the benefit of reducing the harms associated with drug use. Proponents express that the bill is a compassionate approach to drug addiction that directly addresses public health issues. However, potential opposition may arise from individuals concerned about the implications of a needle exchange program, particularly regarding societal perceptions of drug use and addiction.

Contention

While the bill focuses on public health improvements, it may face contention regarding the establishment of needle exchange programs. Critics may argue that such initiatives could inadvertently promote drug use or raise concerns over safety in community settings. Program implementation relies heavily on community buy-in and trust among participants, which could be challenged in areas with high stigma surrounding drug addiction. Additionally, ensuring secure storage and proper handling of exchanged needles will be vital to avoid potential public safety risks.

Companion Bills

No companion bills found.

Similar Bills

CA AB2077

Hypodermic needles and syringes.

CA AB309

Hypodermic needles and syringes.

SC S0255

Safer Syringe Program

NJ A1843

Requires pharmacies to sell hypodermic syringes and needles to any customer over the age of 18 and post sign concerning consumer right to purchase clean syringes and needles.

IL HB2118

HYPODERMIC SYRINGES-SALE

IL SB0437

CRIMINAL LAW-TECH

TX SB1601

Relating to the establishment by certain counties and municipalities of disease control programs to reduce the risk of certain infectious and communicable diseases; authorizing fees.

TX HB1722

Relating to the establishment by certain counties and municipalities of disease control programs to reduce the risk of certain infectious and communicable diseases; authorizing fees.